Cerus Spins Off Immunotherapy Business (AP via Yahoo! Finance)
Biopharmaceutical company Cerus Corp. said Tuesday it spun off its immunotherapy business in order to concentrate on its blood safety technology.
Biopharmaceutical company Cerus Corp. said Tuesday it spun off its immunotherapy business in order to concentrate on its blood safety technology.